InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: ClosetInvestor post# 2668

Saturday, 05/21/2016 1:13:45 PM

Saturday, May 21, 2016 1:13:45 PM

Post# of 233189
I think you may or may not be right. But either way the phase 2b monotherapy results in June 20th IMO will move the share price higher. How much higher? Nobody can predict that, but it should move the needle by a huge margin. I'm more concerned though about a partnership or buyout. Because if the phase 2b monotherapy results are good , Gilead sciences will buyout the company to protect its 44% yearly HIV revenue in the billions. They won't sit on this trust me.!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News